PETQ vs. CELC, LFMD, KALV, INNV, CDMO, OFIX, PROK, ALLO, ALEC, and ABUS
Should you be buying PetIQ stock or one of its competitors? The main competitors of PetIQ include Celcuity (CELC), LifeMD (LFMD), KalVista Pharmaceuticals (KALV), InnovAge (INNV), Avid Bioservices (CDMO), Orthofix Medical (OFIX), ProKidney (PROK), Allogene Therapeutics (ALLO), Alector (ALEC), and Arbutus Biopharma (ABUS). These companies are all part of the "medical" sector.
Celcuity (NASDAQ:CELC) and PetIQ (NASDAQ:PETQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.
Celcuity presently has a consensus target price of $29.00, suggesting a potential upside of 64.12%. PetIQ has a consensus target price of $29.00, suggesting a potential upside of 70.19%. Given Celcuity's higher possible upside, analysts clearly believe PetIQ is more favorable than Celcuity.
Celcuity received 15 more outperform votes than PetIQ when rated by MarketBeat users. Likewise, 66.60% of users gave Celcuity an outperform vote while only 65.53% of users gave PetIQ an outperform vote.
In the previous week, PetIQ had 1 more articles in the media than Celcuity. MarketBeat recorded 2 mentions for PetIQ and 1 mentions for Celcuity. Celcuity's average media sentiment score of 0.00 beat PetIQ's score of -1.25 indicating that PetIQ is being referred to more favorably in the news media.
Celcuity has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, PetIQ has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.
PetIQ has a net margin of 0.19% compared to PetIQ's net margin of 0.00%. Celcuity's return on equity of 11.72% beat PetIQ's return on equity.
63.3% of Celcuity shares are owned by institutional investors. Comparatively, 95.0% of PetIQ shares are owned by institutional investors. 24.3% of Celcuity shares are owned by company insiders. Comparatively, 9.6% of PetIQ shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
PetIQ has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PetIQ, indicating that it is currently the more affordable of the two stocks.
Summary
PetIQ beats Celcuity on 12 of the 15 factors compared between the two stocks.
Get PetIQ News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
